Patent · US Active

Hepatitis C therapies

US7514410B2 · kind B2 · utility

67Cited by

2References

42Claims

0Family size

Assignee

BioCryst Pharmaceuticals, Inc. · US

Inventors

Yarlagadda S. Babu · Birmingham, US
Pooran Chand · Birmingham, US
Minwan Wu · Vestavia Hills, US
Pravin L. Kotian · Hoover, US
V. Satish Kumar · Birmingham, US
Tsu-Hsing Lin · Vestavia Hills, US
Yahya El-Kattan · Hoover, US
Ajit K. Ghosh · Birmingham, US

Key dates

Filing date	Mar 23, 2006
Grant date	Apr 7, 2009
Priority date	—
Expiry date	Mar 9, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.